Neuronetics, Inc. (STIM)Healthcare | Medical Devices | Malvern, United States | NasdaqGM
1.42 USD
+0.02
(1.429%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.45 +0.03 (2.113%) ⇧ (April 17, 2026, 6:48 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:37 p.m. EDT
STIM is a high-risk, low-statsisticaledged trade where the catalyst-heavy narrative (revenue growth + analyst upgrades) is clashing violently with the macro-reality of negative EPS and massive debt load. The forecast models predict a terminal drop, while speculators are gambling on a bounce, but the technical indicators (trading below 200-day MA at -39%) and heavy put open interest suggest this rally lacks the durability to withstand earnings reality. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.204419 |
| AutoETS | 0.432452 |
| MSTL | 0.439320 |
| AutoTheta | 0.464345 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.42 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.666 |
| Excess Kurtosis | -0.65 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 344.143 |
| Revenue per Share | 2.262 |
| Market Cap | 98,802,896 |
| Forward P/E | -4.44 |
| Beta | 0.87 |
| Profit Margins | -26.15% |
| Website | https://neurostar.com/neuronetics |
As of April 18, 2026, 10:37 p.m. EDT: Options positioning reveals a 'long gamma' environment with extremely low implied volatility (~1.6x-1.9x) and positional concentration in out-of-the-money (OTM) strikes (90-98% of OI). This indicates speculators are pushing their gamma exposure minimum to cap prices below current levels. However, there is significant downside hedging activity (ITM puts) on the May and August 2026 expirations at strikes 2.0 and 2.5. With an adjusted predicted direction of -1.1% and high historical volatility, the market is pricing in significant downside risk despite the bullish sentiment in OTM call flow.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6340206 |
| Address1 | 3,222 Phoenixville Pike |
| All Time High | 39.39 |
| All Time Low | 0.52 |
| Ask | 1.49 |
| Ask Size | 19 |
| Audit Risk | 6 |
| Average Analyst Rating | 1.7 - Buy |
| Average Daily Volume10 Day | 2,370,190 |
| Average Daily Volume3 Month | 2,216,498 |
| Average Volume | 2,216,498 |
| Average Volume10Days | 2,370,190 |
| Beta | 0.871 |
| Bid | 1.36 |
| Bid Size | 19 |
| Board Risk | 3 |
| Book Value | 0.324 |
| City | Malvern |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.42 |
| Current Ratio | 2.017 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.505 |
| Day Low | 1.39 |
| Debt To Equity | 344.143 |
| Display Name | Neuronetics |
| Earnings Call Timestamp End | 1,773,750,600 |
| Earnings Call Timestamp Start | 1,773,750,600 |
| Earnings Timestamp | 1,773,750,600 |
| Earnings Timestamp End | 1,777,984,200 |
| Earnings Timestamp Start | 1,777,984,200 |
| Ebitda | -27,631,000 |
| Ebitda Margins | -0.18525 |
| Enterprise To Ebitda | -5.95 |
| Enterprise To Revenue | 1.102 |
| Enterprise Value | 164,403,760 |
| Eps Current Year | -0.47667 |
| Eps Forward | -0.32 |
| Eps Trailing Twelve Months | -0.59 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 610 640 4206 |
| Fifty Day Average | 1.4034 |
| Fifty Day Average Change | 0.016600013 |
| Fifty Day Average Change Percent | 0.011828426 |
| Fifty Two Week Change Percent | -63.40206 |
| Fifty Two Week High | 4.85 |
| Fifty Two Week High Change | -3.4299998 |
| Fifty Two Week High Change Percent | -0.7072165 |
| Fifty Two Week Low | 0.8 |
| Fifty Two Week Low Change | 0.61999995 |
| Fifty Two Week Low Change Percent | 0.7749999 |
| Fifty Two Week Range | 0.8 - 4.85 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,530,192,600,000 |
| Float Shares | 28,855,087 |
| Forward Eps | -0.32 |
| Forward P E | -4.4375 |
| Free Cashflow | -10,412,875 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 658 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.48746 |
| Gross Profits | 72,708,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.31082 |
| Held Percent Institutions | 0.64055 |
| Implied Shares Outstanding | 69,579,508 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. |
| Long Name | Neuronetics, Inc. |
| Market | us_market |
| Market Cap | 98,802,896 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_3177427 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -38,998,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 99,846,593 |
| Number Of Analyst Opinions | 3 |
| Open | 1.43 |
| Operating Cashflow | -20,374,000 |
| Operating Margins | -0.111140005 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Phone | 877 600 7555 |
| Post Market Change | 0.03000009 |
| Post Market Change Percent | 2.1126826 |
| Post Market Price | 1.45 |
| Post Market Time | 1,776,466,108 |
| Previous Close | 1.4 |
| Price Eps Current Year | -2.979 |
| Price Hint | 4 |
| Price To Book | 4.3827157 |
| Price To Sales Trailing12 Months | 0.66240877 |
| Profit Margins | -0.26146 |
| Quick Ratio | 1.469 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.66667 |
| Region | US |
| Regular Market Change | 0.02 |
| Regular Market Change Percent | 1.42857 |
| Regular Market Day High | 1.505 |
| Regular Market Day Low | 1.39 |
| Regular Market Day Range | 1.39 - 1.505 |
| Regular Market Open | 1.43 |
| Regular Market Previous Close | 1.4 |
| Regular Market Price | 1.42 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 1,060,826 |
| Return On Assets | -0.13735 |
| Return On Equity | -1.34858 |
| Revenue Growth | 0.857 |
| Revenue Per Share | 2.262 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 69,579,508 |
| Shares Percent Shares Out | 0.1348 |
| Shares Short | 9,377,645 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 10,258,643 |
| Short Name | Neuronetics, Inc. |
| Short Percent Of Float | 0.2731 |
| Short Ratio | 4.97 |
| Source Interval | 15 |
| State | PA |
| Symbol | STIM |
| Target High Price | 7.0 |
| Target Low Price | 3.0 |
| Target Mean Price | 4.33333 |
| Target Median Price | 3.0 |
| Total Cash | 28,134,000 |
| Total Cash Per Share | 0.406 |
| Total Debt | 90,303,000 |
| Total Revenue | 149,156,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.59 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.360325 |
| Two Hundred Day Average Change | -0.94032514 |
| Two Hundred Day Average Change Percent | -0.39838797 |
| Type Disp | Equity |
| Volume | 1,060,826 |
| Website | https://neurostar.com/neuronetics |
| Zip | 19,355 |